Long term effects of cyclophosphamide treatment on lung function and survival in scleroderma patients with interstitial lung disease
{{output}}
Background: Scleroderma (SSc) patients with active interstitial lung disease (ILD) experience a decline in lung function and increased mortality; cyclophosphamide (CYC) therapy may stabilize lung function at one and two years fol... ...
